Rubius Therapeutics (RUBY) Stock Discussions on Social Media

FDA history tells us i takes around 12 years from drug invention to FDA approval for market. At RUBYs cash burn rate that means the company needs about $2Billion more to stay active as a going concern. That is consistent with the average cost of the FDA historical approval process of 12 years and $2.6Billion. This indicates shareholders need to put on their big boy pants and get used to waiting and watching share dilution gradually take away their investment. I would be a buyer when shares erode to the $2 - $5 ballpark in a few years just before FDA Phase1 results are documented and announced. No science or special data, just an opinion.

🚀 ⚕️ The 6 Best Stem Cell Stocks To Buy Right Now ⚕️ 🚀 For details https://youtu.be/xZZEi-kNwV0

This is the safest and cheapest way to treat cancer by high and repeat doses.

All manipulation tricking you to buy only to see It drop like a bullet. I see the Same pattern all over the stock market targetting retail. Dark pool trading hard at work.

Today let see 40

Trading doesn’t have to be about losing all the time. It doesn’t have to be about letting the markets pummel you day in day out. Fight back with (http://Pick-stocks.com). Beef up your defenses and join them.

Buy at $24.5

They are months and months away from any indication that they will make money. Poor financial structure to support them if they ever make a dollar, not good management, and their product hasn't even been proved not to kill people yet. Who tf did research AND bought? not me. Puts all day this bad boy going down like the titanic

I just bought a bit. it may be another $sava or $ruby! just bet on it!

What is the offering price?

How does this happen? Look at the fundamentals----- No sellable product and no income history, carrying large debt, share dilution underway, no FDA phase 2 or 3 trial, anecdotal drug result on a small sample with unclear experimental design, a time horizon of years to market approval, lots of ongoing tech competition, inadequate funds to complete a trial..... This stock would appear to be a prime candidate for shorting. By contrast look at another Langer company, NVIV. It is only a dollar. And has cash runway to mid 2023, FDA phase 3 underway, data showing its scaffold doubles chances of conversion from complete spinal paralysis, could be through Phase 3 inside of 2 years since recruitment is now more than 50% complete. Carrying zero debt.....Seems like NVIV ought to be the one everybody is jumping on. Just sayin and wondering what drives RUBY.

Any moment can announce offer closed, companies usually Pop 50%-100% after announcement due to Squeeze.

Not to seem obtuse, but pricing the new shares at 29.00 to raise emough money to bring a probable cancer cure to market, and THEN falling 25% in one day, makes no logical sense to me. Just saying.

A bit oversold at this point.

why would a $32 stock need to sell more shares??? Bad sign!!!!

I was surprised this jumped so high, still has a long way to go.

I know it feels good, but you gotta learn when to pull out or else you end up with kids

What do we think is a good buy in price?

if they still those shares to institutions at 29, I feel good owning it at 27...

Love to see a big crash below $25 today